Umbilical cord blood processor


Intravenous products: The FDA has given clearance to PrepaCyte-CB umbilical cord blood processing system from BioE Inc. out of St. Paul, Minnesota. The device, already approved in the EU, filters blood for progenitor stem cells, total nucleated cells, and mononucleated cells for a possible use in therapeutic applications.

Click here for the full story on medgadget.

Click here for the press release.

Thank you to our partners for supporting IVTEAM


Comments are closed.